Temozolomide (Lannett Company, Inc.)
Welcome to the PulseAid listing for the Temozolomide drug offered from Lannett Company, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lannett Company, Inc. |
| NON-PROPRIETARY NAME: | Temozolomide |
| SUBSTANCE NAME: | TEMOZOLOMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-03-23 |
| END MARKETING DATE: | 0000-00-00 |
Temozolomide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Temozolomide from Lannett Company, Inc. |
| LABELER NAME: | Lannett Company, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2016-03-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0527-1777_c06a20ea-8ac5-4611-a90b-00265e84f497 |
| PRODUCT NDC: | 0527-1777 |
| APPLICATION NUMBER: | ANDA202750 |
Other TEMOZOLOMIDE Pharmaceutical Manufacturers / Labelers:
